QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 7, 2008, 28(19):4861-4871; doi:10.1523/JNEUROSCI.0525-08.2008

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Press, C. Articles by Milbrandt, J. Search for Related Content PubMed PubMed Citation Articles by Press, C. Articles by Milbrandt, J.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress

Craig Press and Jeffrey Milbrandt

Department of Pathology, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri 63110

Correspondence should be addressed to Jeffrey Milbrandt at the above address. Email: jmilbrandt{at}wustl.edu

Axonal degeneration is a prominent feature of many neurological disorders that are associated with mitochondrial dysfunction, including Parkinson's disease, motor neuron disease, and inherited peripheral neuropathies. Studies of the Wld^s mutant mouse, which undergoes delayed Wallerian degeneration in response to axonal injury, suggest that axonal degeneration is an active process. Wld^s mice also have slower axonal degeneration and disease progression in numerous models of neurodegenerative disease. The Wld^s mutation results in the production of a chimeric protein that contains the full-length coding sequence of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1), which alone is sufficient for axonal protection in vitro. To test the effects of increased Nmnat expression on axonal degeneration induced by mitochondrial dysfunction, we examined dorsal root ganglion (DRG) neurons treated with rotenone. Rotenone induced profound axonal degeneration in DRG neurons; however, this degeneration was delayed by expression of Nmnat. Nmnat-mediated protection resulted in decreased axonal accumulation and sensitivity to reactive oxygen species (ROS) but did not affect the change in the rate of rotenone-induced loss in neuronal ATP. Nmnat also prevented axonal degeneration caused by exposure to exogenous oxidants and reduced the level of axonal ROS after treatment with vincristine, further supporting the idea that Nmnat promotes axonal protection by mitigating the effects of ROS.

Key words: Nmnat; Wld^s; axonal degeneration; mitochondria; ROS; ATP

---

Received July 16, 2007; revised March 13, 2008; accepted March 26, 2008.

Correspondence should be addressed to Jeffrey Milbrandt at the above address. Email: jmilbrandt{at}wustl.edu

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2008 28: i. [Full Text]  

This article has been cited by other articles:

				Y. Sasaki, B. P. S. Vohra, R. H. Baloh, and J. Milbrandt Transgenic Mice Expressing the Nmnat1 Protein Manifest Robust Delay in Axonal Degeneration In Vivo J. Neurosci., May 20, 2009; 29(20): 6526 - 6534. [Abstract] [Full Text] [PDF]

				N. Yahata, S. Yuasa, and T. Araki Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian Degeneration J. Neurosci., May 13, 2009; 29(19): 6276 - 6284. [Abstract] [Full Text] [PDF]

				Y. Sasaki, B. P. S. Vohra, F. E. Lund, and J. Milbrandt Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide J. Neurosci., April 29, 2009; 29(17): 5525 - 5535. [Abstract] [Full Text] [PDF]

				L. Conforti, A. Wilbrey, G. Morreale, L. Janeckova, B. Beirowski, R. Adalbert, F. Mazzola, M. Di Stefano, R. Hartley, E. Babetto, et al. WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice J. Cell Biol., February 23, 2009; 184(4): 491 - 500. [Abstract] [Full Text] [PDF]

				M. A. Avery, A. E. Sheehan, K. S. Kerr, J. Wang, and M. R. Freeman WldS requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration J. Cell Biol., February 23, 2009; 184(4): 501 - 513. [Abstract] [Full Text] [PDF]

				B. Beirowski, E. Babetto, J. Gilley, F. Mazzola, L. Conforti, L. Janeckova, G. Magni, R. R. Ribchester, and M. P. Coleman Non-Nuclear WldS Determines Its Neuroprotective Efficacy for Axons and Synapses In Vivo J. Neurosci., January 21, 2009; 29(3): 653 - 668. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help